Using electricity to improve chemical reactions for better efficiency and selectivity
Electrically Driven C-H Functionalization with CuII/CuIII Redox Catalysts
['FUNDING_R01'] · OHIO STATE UNIVERSITY · NIH-11086662
This study is exploring new ways to use electricity to make important chemical reactions easier and more efficient, which could eventually help create better medicines and products for patients like you.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OHIO STATE UNIVERSITY (nih funded) |
| Locations | 1 site (Columbus, UNITED STATES) |
| Trial ID | NIH-11086662 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative methods that use electrical energy to enhance C-H functionalization reactions, which are important in chemical synthesis. By employing CuII/CuIII redox catalysts, the project aims to reduce the need for excessive strong oxidants, leading to lower costs and improved selectivity in chemical processes. The approach involves generating specific complexes that allow for more efficient reactions at lower energy levels, making the process more sustainable and effective. Patients may benefit indirectly through advancements in drug development and chemical manufacturing that arise from these improved methods.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals involved in pharmaceutical development or those interested in advancements in chemical manufacturing.
Not a fit: Patients who are not involved in chemical industries or do not have a direct interest in pharmaceutical advancements may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient and cost-effective methods for producing pharmaceuticals and other important chemicals.
How similar studies have performed: Other research has shown promise in using electrical methods for chemical reactions, indicating that this approach could lead to significant advancements.
Where this research is happening
Columbus, UNITED STATES
- OHIO STATE UNIVERSITY — Columbus, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZHANG, SHIYU — OHIO STATE UNIVERSITY
- Study coordinator: ZHANG, SHIYU
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.